To Editor:
Haemoglobin (Hb) is the oxygen-carrying moiety of erythrocytes. It is a polypeptide tetramer consisting of two pairs of unlike globin chains (α plus β, δ, or γ), which form a shell around a central cavity containing four oxygen-binding haeme groups; each covalently linked to a globin chain. In healthy adults, ~ 95% of the Hb is A (α2β2) with small amounts of HbA2 (α2δ ) and HbF (α2γ2) present. The α-globin gene is encoded in duplicate on chromosome 16, and the non-α chains (β , δ , γ) are encoded in a cluster on chromosome 11. 1 Alpha thalassaemia (α-thal) represents a heterogeneous group of clinical conditions characterised by reduction or suppression in synthesis of the α-globin chain, resulting in the formation of erythrocytes with an inadequate content of Hb and, therefore, microcytic and hypochromic. The imbalance between the synthesis of α-and β-globin chains in adults results in the accumulation of β-globin chains, which are produced in a normal rhythm. The excess β-globin chains are unstable and precipitate intracellularly, causing alterations in the membrane and cellular metabolism, that result, in the destruction of the erythroblasts in the bone marrow (ineffective erythropoiesis) or spleen (haemolysis) and anaemia.
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α-thal is caused particularly by an inherited deletion of the α-globin genes and its clinical severity is determined by the number of inherited genes. Patients with two or three alpha genes do not present symptoms and are only identified with certainty, by molecular analysis. Three alpha gene deletions lead to a moderately to severe microcytic, hypochromic anaemia with splenomegaly, which is frequently erroneously treated with iron compounds and red blood cell transfusion. This form of α-thal is known as Hb H disease, since Hb (β 4 ) can be detected in erythrocyte preparations stained with brilliant cresyl blue or electrophoresis of Hb. [2] [3] [4] [5] The loss of all α-genes leads to death in the uterus (hydrops fetalis). [2] [3] [4] The diagnostic definition of this illness is, in general, confirmed by molecular studies, where the most usual are the Mediterranean deletions (loss of two alleles of the same chromosome) in Caucasians and 3.7 deletion (loss of one out of two alleles of the same chromosome) in African descendents. [6] [7] [8] Herein, we present for educational purposes, the case of a patient attended in our clinic and diagnosed with Hb H disease, who had received erroneous treatment for anaemia in other services.
The patient was a 50-year-old medium-brunette female referred to our unit due to weakness, mucosal cutaneous pallor and jaundice over 30 years. She had received treatment with red blood cell transfusion and oral iron compounds sporadically during her life. Mucosal cutaneous pallor, hepatomegaly and splenomegaly were identified during the physical examination.
At this time, the peripheral blood examination showed: RBC: 4.8x10 (Figure 2 ), suggesting the presence of Hb H. 9 Electrophoresis of Hb showed Hb A2 + Hb A + Hb H. Hb A2: 1.3% (normal: 1.5 to 3.5%), Hb F: 1.1% (normal: < 2.0%) and Hb H: 9.7% (Figure 3) . Mediterranean deletion and the 3.7 deletion were demonstrated by molecular studies 7, 8 ( Figure 4) .
The patient received the diagnosis of Hb H disease and received 5 mg of folic acid orally per day as therapy. In addition, she was advised to avoid therapies with iron compounds or red blood cell transfusion and to direct members of her family to our service for genetic counselling. 
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